For isolated or predominant endogenous hypertriglyceridemia in patient at risk of ischemic heart disease and or pancreatitis.
Endogenous hypertriglyceridemia as a supplement to diet when dietary measures alone are insufficient to produce an adequate response: type IV in monotherapy; type llb/III in combination with statins, when control of triglycerides is insufficient.
Other Services
Country
Support
Account
Sign Out